1. Sammons, JS, Toltzis, P. Recent trends in the epidemiology and treatment of C. difficile infection in children. Curr Opin Pediatr 2013;25:116–121.
2. Wendt, JM, Cohen, JA, Mu, Y, et al.
Clostridium difficile infection among children across diverse US geographic locations. Pediatrics 2014;133:651–658.
3. Jangi, S, Lamont, JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 2010;51:2–7.
4. Guyatt, GH, Oxman, AD, Vist, GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924–926.
5. McDonald, LC, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66:e1–e48.
6. Dubberke, ER, Han, Z, Bobo, L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol 2011;49:2887–2893.
7. Sherertz, RJ, Sarubbi, FA. The prevalence of Clostridium difficile and toxin in a nursery population: a comparison between patients with necrotizing enterocolitis and an asymptomatic group. J Pediatr 1982;100:435–439.
8. Rousseau, C, Lemee, L, Le Monnier, A, Poilane, I, Pons, JL, Collignon, A. Prevalence and diversity of Clostridium difficile strains in infants. J Med Microbiol 2011;60:1112–1118.
9. Tamma, PD, Sandora, TJ.
Clostridium difficile infection in children: current state and unanswered questions. J Pediatric Infect Dis Soc 2012;1:230–243.
10. Adlerberth, I, Huang, H, Lindberg, E, et al. Toxin-producing Clostridium difficile strains as long-term gut colonizers in healthy infants. J Clin Microbiol 2014;52:173–179.
11. Schutze, GE, Willoughby, RE.
Clostridium difficile infection in infants and children. Pediatrics 2013;131:196–200.
12. Naing, Z, Rayner, B, Killikulangara, A, et al. Prevalence of viruses in stool of premature neonates at a neonatal intensive care unit. J Paediatr Child Health 2013;49:E221–E226.
13. Shim, JO, Son, DW, Shim, SY, Ryoo, E, Kim, W, Jung, YC. Clinical characteristics and genotypes of rotaviruses in a neonatal intensive care unit. Pediatr Neonatol 2012;53:18–23.
14. Stuart, RL, Tan, K, Mahar, JE, et al. An outbreak of necrotizing enterocolitis associated with norovirus genotype GII.3. Pediatr Infect Dis J 2010;29:644–647.
15. Turcios-Ruiz, RM, Axelrod, P, St John, K, et al. Outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit. J Pediatr 2008;153:339–344.
16. Kusuhara, K, Saito, M, Sasaki, Y, et al. An echovirus type 18 outbreak in a neonatal intensive care unit. Eur J Pediatr 2008;167:587–589.
17. Finn, A, Anday, E, Talbot, GH. An epidemic of adenovirus 7a infection in a neonatal nursery: course, morbidity, and management. Infect Control Hosp Epidemiol 1988;9:398–404.
18. Faden, H, Patel, PH, Campagna, L. Pitfalls in the diagnosis of enteroviral infection in young children. Pediatr Infect Dis J 2006;25:687–690.
19. Boehmer, TK, Bamberg, WM, Ghosh, TS, et al. Health care-associated outbreak of Salmonella Tennessee in a neonatal intensive care unit. Am J Infect Control 2009;37:49–55.
20. Taneja, N, Das, A, Raman Rao, DS, Jain, N, Singh, M, Sharma, M. Nosocomial outbreak of diarrhoea by enterotoxigenic Escherichia coli among preterm neonates in a tertiary care hospital in India: pitfalls in healthcare. J Hosp Infect 2003;53:193–197.
21. Gross, RJ, Rowe, B, Henderson, A, Byatt, ME, Maclaurin, JC. A new Escherichia coli O-group, O159, associated with outbreaks of enteritis in infants. Scand J Infect Dis 1976;8:195–198.
22. Gaynes, RP, Simpson, D, Reeves, SA, et al. A nursery outbreak of multiple-aminoglycoside-resistant Escherichia coli
. Infect Control 1984;5:519–524.
23. Buss, SN, Leber, A, Chapin, K, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol 2015;53:915–925.
24. Planche, TD, Davies, KA, Coen, PG, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection. Lancet Infect Dis 2013;13:936–945.
25. Toltzis, P, Nerandzic, MM, Saade, E, et al. High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients. Infect Control Hosp Epidemiol 2012;33:175–179.
26. Bryant, K, McDonald, LC.
Clostridium difficile infections in children. Pediatr Infect Dis J 2009;28:145–146.
27. Mohan, SS, McDermott, BP, Parchuri, S, Cunha, BA. Lack of value of repeat stool testing for Clostridium difficile toxin. Am J Med 2006;119:356 e7–e8.
28. Luo, RF, Banaei, N. Is repeat PCR needed for diagnosis of Clostridium difficile infection? J Clin Microbiol 2010;48:3738–3741.
29. Aichinger, E, Schleck, CD, Harmsen, WS, Nyre, LM, Patel, R. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol 2008;46:3795–3797.
30. Peterson, LR, Robicsek, A. Does my patient have Clostridium difficile infection
? Ann Intern Med 2009;151:176–179.
31. Dubberke, ER, Carling, P, Carrico, R, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35:628–645.
32. Surawicz, CM, Brandt, LJ, Binion, DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013;108:478–498.
34. McFarland, LV, Mulligan, ME, Kwok, RY, Stamm, WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204–210.
35. Samore, MH, Venkataraman, L, DeGirolami, PC, Arbeit, RD, Karchmer, AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996;100:32–40.
36. Dubberke, E, Reske, K, Noble-Wang, J, et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control 2007;35:315–318.
37. El Feghaly, R, Stauber, J, Deych, E, Gonzalez, C, Tarr, P, Haslam, D. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis 2013;56:1713–1721.
38. Golan, Y, Doron, S, Sullivan, B, Snydman, DR. Transmission of vancomycin-resistant Enterococcus in a neonatal intensive care unit. Pediatr Infect Dis J 2005;24:566–567.
39. Fowler, S, Webber, A, Cooper, BS, et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimicrob Chemother 2007;59:990–995.
40. Cotten, CM, Taylor, S, Stoll, B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009;123:58–66.
41. Cotten, CM, McDonald, S, Stoll, B, Goldberg, RN, Poole, K, Benjamin, DK Jr. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006;118:717–722.